{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:54:48Z","timestamp":1780970088236,"version":"3.54.1"},"reference-count":21,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2025.2025.0245","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:03:56Z","timestamp":1754985836000},"source":"Crossref","is-referenced-by-count":2,"title":["A Multicenter, Retrospective Study Comparing Immunosuppressive Therapy Combined with Eltrombopag to Immunosuppressive Therapy Alone as Front-Line Treatment for Pediatric Severe Aplastic Anemia"],"prefix":"10.4274","author":[{"given":"Didem","family":"Atay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Y\u0131lmaz Karap\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca","family":"Ka\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Karadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi","family":"Apak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Fatih","family":"\u00c7akmakl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysha","family":"Gadashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tekin","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiraje","family":"Celkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne\u015fe","family":"Yaral\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Fatih","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ertem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Ayta\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"\u00d6ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Akbayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eebnem","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"\u0130leri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"B\u00fcy\u00fckavc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Karak\u00fckc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba Hilkay","family":"Karap\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Erbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"Eker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davut","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eule","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref0","unstructured":"1. EWOG-SAA. Consensus for the Treatment of Severe Aplastic Anaemia in Children and Adolescents. Freiburg, EWOG-SAA, 2023. Available online at https:\/\/ewog-mds-saa.org\/fileadmin\/mediapool\/10_andere\/ewog-mds\/pdf\/protocoldocs\/Concensus_for_treatment_of_SAA_v1.7.pdf."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"SB","year":"2016","unstructured":"2. Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JC; British Society for Standards in Haematology. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187-207.","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1182\/bloodadvances.2023011642","article-title":"Modified Delphi panel consensus recommendations for management of severe aplastic anemia","volume":"8","author":"Babushok","year":"2024","unstructured":"3. Babushok DV, DeZern AE, de Castro CM, Rogers ZR, Beenhouwer D, Broder MS, Fanning SR, Gibbs SN, Hanna R, Maciejewski JP, Scott BL, Tantravahi SK, Wlodarski MW, Yermilov I, Patel BJ. Modified Delphi panel consensus recommendations for management of severe aplastic anemia. Blood Adv. 2024;8:3946-3960.","journal-title":"Blood Adv"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","article-title":"Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party","volume":"119","author":"JC","year":"2012","unstructured":"4. Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, Killick SB, Warren AJ, Foukaneli T, Aljurf M, Al-Zahrani HA, H\u00f6chsmann B, Schafhausen P, Roth A, Franzke A, Brummendorf TH, Dufour C, Oneto R, Sedgwick P, Barrois A, Kordasti S, Elebute MO, Mufti GJ, Socie G; European Blood and Marrow Transplant Group Severe Aplastic Anaemia Working Party. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood. 2012;119:5391-5396.","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","unstructured":"5. Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365:430-438.","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2012-11-465633","article-title":"Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia","volume":"121","author":"Takahashi","year":"2013","unstructured":"6. Takahashi Y, Muramatsu H, Sakata N, Hyakuna N, Hamamoto K, Kobayashi R, Ito E, Yagasaki H, Ohara A, Kikuchi A, Morimoto A, Yabe H, Kudo K, Watanabe K, Ohga S, Kojima S; Japan Childhood Aplastic Anemia Study Group. Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia. Blood. 2013;121:862-863.","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3324\/haematol.2013.089268","article-title":"Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children","volume":"99","author":"Jeong","year":"2014","unstructured":"7. Jeong DC, Chung NG, Cho B, Zou Y, Ruan M, Takahashi Y, Muramatsu H, Ohara A, Kosaka Y, Yang W, Kim HK, Zhu X, Kojima S. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children. Haematologica. 2014;99:664-671.","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","unstructured":"8. Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017;376:1540-1550.","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood.V87.6.2162.bloodjournal8762162","article-title":"Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl","volume":"87","author":"Alexander","year":"1996","unstructured":"9. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996;87:2162-2170.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.stem.2007.10.008","article-title":"Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells","volume":"1","author":"Qian","year":"2007","unstructured":"10. Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, M\u00e5nsson R, Thoren LA, Ekblom M, Alexander WS, Jacobsen SE. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2007;1:671-684.","journal-title":"Cell Stem Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","article-title":"Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug","volume":"123","author":"Desmond","year":"2014","unstructured":"11. Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014;123:1818-1825.","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","unstructured":"12. Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012;367:11-19.","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1002\/cncr.31658","article-title":"Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia","volume":"124","author":"Assi","year":"2018","unstructured":"13. Assi R, Garcia-Manero G, Ravandi F, Borthakur G, Daver NG, Jabbour E, Burger J, Estrov Z, Dinardo CD, Alvarado Y, Hendrickson S, Ferrajoli A, Wierda W, Cortes J, Kantarjian H, Kadia TM. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia. Cancer. 2018;124:4192-4201.","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"de Latour R","year":"2022","unstructured":"14. Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, S\u00e1nchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Soci\u00e9 G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022; 386:11-23.","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1007\/s00277-024-05910-w","article-title":"Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence","volume":"103","author":"Li","year":"2024","unstructured":"15. Li X, Shangguan X, Wang H, Wang Q, Zhang Y, Han B, Liu R, Zhang F, Fu R, Lin Z, Miao M, Ma X, Lei M, Wu D, Liu L. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence. Ann Hematol. 2024;103:3483-3491.","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/bjh.17232","article-title":"Eltrombopag added to immunosuppression for children with treatment-na\u00efve severe aplastic anaemia","volume":"192","author":"Groarke","year":"2021","unstructured":"16. Groarke EM, Patel BA, Gutierrez-Rodrigues F, Rios O, Lotter J, Baldoni D, St Pierre A, Shalhoub R, Wu CO, Townsley DM, Young NS. Eltrombopag added to immunosuppression for children with treatment-na\u00efve severe aplastic anaemia. Br J Haematol. 2021;192:605-614.","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1095143","DOI":"10.3389\/fped.2022.1095143","article-title":"Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia","volume":"10","author":"Zhao","year":"2023","unstructured":"17. Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, Li J, Ye L, Xiong Y, Yang Y, Zhang B, Li X, Yang X, Shi Y, Peng G, Li Y, Fan H, Zhou K, Jing L, Zhang L, Zhang F. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia. Front Pediatr. 2023;10:1095143.","journal-title":"Front Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1182\/blood.V45.3.355.355","article-title":"Selection of patients for bone marrow transplantation in severe aplastic anemia","volume":"45","author":"Camitta","year":"1975","unstructured":"18. Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood. 1975;45:355-363.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1182\/bloodadvances.2021006716","article-title":"Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia","volume":"7","author":"Goronkova","year":"2023","unstructured":"19. Goronkova O, Novichkova G, Salimova T, Kalinina I, Baidildina D, Petrova U, Antonova K, Sadovskaya M, Suntsova E, Evseev D, Matveev V, Venyov D, Khachatryan L, Litvinov D, Pshonkin A, Ovsyannikova G, Kotskaya N, Gobadze D, Olshanskaya Y, Popov A, Raykina E, Mironenko O, Voronin K, Purbueva B, Boichenko E, Dinikina Y, Guseynova E, Sherstnev D, Kalinina E, Mezentsev S, Streneva O, Yudina N, Plaksina O, Erega E, Maschan M, Maschan A. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia. Blood Adv. 2023;7:953-962.","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3324\/haematol.2021.278413","article-title":"Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag","volume":"107","author":"Zaimoku","year":"2022","unstructured":"20. Zaimoku Y, Patel BA, Shalhoub R, Groarke EM, Feng X, Wu CO, Young NS. Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag. Haematologica. 2022;107:126-133.","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12185-024-03903-z","article-title":"Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia","volume":"121","author":"Eguchi","year":"2025","unstructured":"21. Eguchi K, Ishimura M, Ohga S, Endo S, Saito S, Kamimura S, Keino D, Kato S, Azuma Y, Watanabe A, Inoue A, Higa T, Ozono S, Fujita N, Watanabe K, Takahashi Y; Japan Childhood Aplastic Anemia Study Group. Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia. Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia. Int J Hematol. 2025;121:533-542.","journal-title":"Int J Hematol"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T14:23:02Z","timestamp":1756736582000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-97345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":21,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2025.2025.0245","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}